Denali Therapeutics
This role leads Denali's global Health Economics and Outcomes Research (HEOR) strategy for ex-US markets, focusing on generating evidence to secure patient access and support regulatory submissions. The position involves developing core health economic models, managing real-world evidence studies, and partnering with cross-functional teams to align evidence generation with clinical development and launch objectives. The successful candidate will engage with HTA bodies and payers to inform evidence strategies and support reimbursement negotiations across European and international markets.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2015
Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Denali Therapeutics.
Denali Therapeutics didn’t post a salary, so this is our estimate from similar listings.
International HEOR Lead
BridgeBio Pharma
Director, HEOR & RWE, Europe
Revolution Medicines
Health Economics & Outcomes Research Sr Manager, Obesity
Amgen
Health Economics and Outcomes Research (HEOR) Fellowship
Northeastern University
Global Health Economics & Outcomes Research (HEOR) Senior Manager
lifelancer
Health Economics & Outcomes Research (HEOR) Senior Manager, Oncology
lifelancer